You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Cancer Trials

We offer a number of clinical trials for cancer. Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 6 | Results 1 - 10 of 55

A Home-Based Study to Enhance Activity in Breast Cancer Survivors

Grace Makari-Judson, MD
Cancer, Cancer - Breast

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

A Phase 3 Comparison of Platinum-Based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-Based Therapy as First-Line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer (FIRST)

Tashanna Myers, MD
Cancer, Cancer-Gynecologic

Baystate Medical Center, 759 Chestnut St, Springfield, MA

Recruiting

A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial

Tashanna Myers, MD
Cancer, Cancer-Gynecologic

  • D’Amour Center for Cancer Care, 3350 Main Street , Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA
  • Baystate Mary Lane Outpatient Center, 85 South Street, Ware, MA

Active

A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (IMagyn050)

Tashanna Myers, MD
Cancer-Gynecologic, Cancer

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

A Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Tashanna Myers, MD
Cancer, Cancer-Gynecologic

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

A phase II trial of chemotherapeutic agents in patients with diffuse large B-Cell lymphoma

The purpose of this study is to find out what effects, good and/or bad, the addition of lenalidomide to standard chemotherapy (RCHOP)
Syed Ali, MD
Cancer - Lymphoma, Cancer

  • D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA

Active

A phase III trial of medications for castration resistance in metastatic prostate cancer

The purpose of this study is to compare the effects, good and/or bad, of abiraterone, prednisone, and enzalutamide with enzalutamide alone on you and your prostate cancer to find out which is better.
Leslie Howard, MD
Cancer - Prostate, Cancer

  • D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA

Active

A phase III trial to combine the effects of a group of medications with another combination in patients with newly diagnosed Symptomatic Multiple Myeloma

This randomized phase III trial studies lenalidomide, dexamethasone, and bortezomib to see how well it works compared to dexamethasone and lenalidomide alone in treating patients with previously untreated multiple myeloma. Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Drugs used in chemotherapy, such as dexamethasone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth or by blocking blood flow to the cancer. It is not yet known whether lenalidomide and dexamethasone is more effective with or without bortezomib in treating multiple myeloma.
Syed Ali, MD
Cancer - Leukemia, Cancer

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

A phase III trial to study Esophageal Adenocarcinoma

Seth Kaufman, MD
Cancer - Esophogus, Cancer

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

A study to evaluate drug combination therapy in gynecologic cancer

The purpose of this study is to find out if the drug combination of paclitaxel, carboplatin and metformin works better than paclitaxel and carboplatin alone and to find out what side effects are caused by treatment with these drugs.
Tashanna Myers, MD
Cancer-Gynecologic, Cancer

  • D’Amour Center for Cancer Care, 3350 Main Street , Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA

Active
Page 1 of 6 | Results 1 - 10 of 55